AVE 0.00% 0.3¢ avecho biotechnology limited

Terumo and Propofol Injectable, page-3

  1. 2,810 Posts.
    lightbulb Created with Sketch. 517
    MS
    Well spotted
    In my opinion this profotol patent is all POH scientist's own work without any Terumo input at this time.
    To support this view I can highlight the following:
    1.The applicant is Phosphagenics only and the inventor is an employee of Phosphagenics. The old POH company address is quoted in the document.
    2.The priority date for Australia is 9/12/2015.
    3.The priority date for the US is 28/4/2016 which is the day before the Terumo/Phosphagenics R&D research agreement was signed.
    4.When the Terumo R&D research agreement was signed it was indicated in that announcement that POH had already developed a profotol prototype product.
    Kens
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
63 90918113 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 58054085 14
View Market Depth
Last trade - 10.00am 23/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.